Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells

doi:10.12047/j.cjap.6200.2022.013

Abstract

Abstract: Objective: To investigate the mechanism that hypoxia promotes the migration of lung adenocarcinoma A549 cells. Methods: A549 cells were cultured and cells that knockdown of acetyl-CoA carboxylase 1 (ACC1) were obtained by transfection with lentivirus, and cells that knockdown of sterol regulatory element-binding proteins-1 (SREBP-1) were obtained by treated with si-RNA. A549 cells were treated with hypoxia combined with hypoxia inducible factor-1α (HIF-1α) inhibitor PX-478 (25 μmol); Hypoxia combined with linoleic acid (LA) (20 μmol) treated A549 cells with ACC1 knockdown, and A549 cells with SREBP-1 knockdown were treated by hypoxia. Transwell migration assay was used to detect cell migration. Western blot was conducted to detect HIF-1α, ACC1 and epithelial mesenchymal transition (EMT) related proteins, Vimentin, E-Cadherin and SREBP-1; Real-time fluorescent quantitative polymerase chain reaction (RT-qPCR) was performed to detect the changes of ACC1 and SREBP-1 mRNA in A549 cells after hypoxia and HIF-1α inhibitor PX-478 (25 μmol) treatment. Each experiment was repeated three times. Results: Compared with the normoxic control group, hypoxia promoted the migration of A549 cells (P＜0.01), and up-regulated the expressions of ACC1, HIF-1α (all P＜0.01) and SREBP-1 (P＜0.05). PX-478 (25 μmol) inhibited the migration of A549 cells induced by hypoxia and down-regulated the expression of SREBP-1 (all P＜0.05). ACC1 mRNA and SREBP-1 mRNA levels were increased after hypoxia treatment of A549 cells (all P＜0.05). The levels of ACC1 mRNA and SREBP-1 mRNA were decreased after A549 cells treated with hypoxia combined with PX-478 (25 μmol) for 24 h (P＜0.05, P＜0.01). Knockdown of SREBP-1 in A549 cells was obtained by transfection with si-RNA. Transwell migration assay showed the number of cell migration in si-SREBP-1 group was less than that in normoxia control group (P＜0.01). The si-SREBP-1 group and the si-NC group were treated with hypoxia. Compared with the control group, the number of cell migration in the si-SREBP-1 group was decreased (P＜0.01), however, the difference was not statistically significant compared with the normoxia si-SREBP-1 group (P＞0.05). Western blot showed that the expression of ACC1 in the si-SREBP-1 group was lower than that in the control group (P＜0.01). Compared with the control group, the expression of ACC1 was decreased after si-SREBP-1 group treated with hypoxia (P＜0.01). Knockdown of ACC1 inhibited the migration of A549 cells (P＜0.05). After knockdown of ACC1, the migration number of A549 cells under normoxia and 5% O₂ conditions had no significant difference (P＞0.05). Application of LA under hypoxia condition rescued ACC1-knockdown induced inhibitory effect on hypoxia-promoted A549 cell migration (P＜0.05). Conclusion: Hypoxia promotes migration of lung adenocarcinoma A549 cells by regulating fatty acid metabolism through HIF-1α/SREBP-1/ACC1 pathway.

Key words: lung adenocarcinoma, hypoxia, acetyl-CoA carboxylase 1, hypoxia inducible factor 1 α, sterol regulatory element binding protein 1, migration

CLC Number:

R734-2

JIN Jia-hao, ZHAO Bao-sheng, LIU Yu-zhen. Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells[J]. CJAP, 2022, 38(1): 68-74.

References

[1] Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship[J]. Mayo Clin Proc, 2008, 83(5): 584-594.
[2] Eggert JA, Palavanzadeh M, Blanton A. Screening and early detection of lung cancer[J]. Semin Oncol Nurs, 2017, 33(2): 129-140.
[3] Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro[J]. Cancer Res, 1953, 13(1): 27-29.
[4] Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer[J]. Br J Cancer, 2020, 122(1): 4-22.
[5] Sormendi S, Wielockx B. Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment[J]. Front Immunol, 2018, 29: 9-40.
[6] Zuo J, Wen J, Lei M, et al. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT[J]. Med Oncol, 2016, 33(2): 15.
[7] Liu L, Ning X, Sun L, et al. Hypoxia inducible factor1- 1α contributes to hypoxia-induced chemoresistance in gastric cancer[J]. Cancer Sci, 2008, 99(1): 121-128.
[8] 金家豪, 赵宝生, 刘丹辉, 等. 低氧通过上调乙酰辅酶A羧化酶1促进肺腺癌A549细胞迁移[J]. 解剖学报, 2021, 52(2): 258-263.
[9] McGuirk S, Audet-Delage Y, St-Pierre J. Metabolic fitness and plasticity in cancer progression[J]. Trends Cancer, 2020, 6(1): 49-61.
[10] Junttila MR, de Sauvage FJ.Influence of tumour micro-environment heterogeneity on therapeutic response[J]. Nature, 2013, 501(7467): 346-354.
[11] Dutta A, Sharma-Walia N. Curbing lipids: Impacts on cancer and viral infection[J]. Int J Mol Sci, 2019, 20(3): 644.
[12] Tang Z, Xu Z, Zhu X, et al. New insights into molecules and pathways of cancer metabolism and therapeutic implications[J]. Cancer Commun (Lond), 2021, 41(3): 16-36.
[13] Wang J, Wu X. The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome[J]. Endokrynol Pol, 2020, 71(2): 134-145.
[14] Ezzeddini R, Taghikhani M, Somi MH, et al. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma[J]. Life Sci, 2019, 224(1): 169-176.
[15] Guo D, Bell EH, Mischel P, et al. Targeting SREBP-1-driven lipid metabolism to treat cancer[J]. Curr Pharm Des, 2014, 20(15): 2619-2626.
[16] Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology- divergent pathophysiology[J]. Nat Rev Endocrinol, 2017, 13(12): 710-730.
[17] Cheng C, Geng F, Cheng X, et al. Lipid metabolism reprogramming and its potential targets in cancer[J]. Cancer Commun (Lond), 2018, 38(1): 27.
[18] Hapke RY, Haake SM. Hypoxia-induced epithelial to mesenchymal transition in cancer[J]. Cancer Lett, 2020, 487(1): 10-20.
[19] Hunkeler M, Hagmann A, Stuttfeld E, et al. Structural basis for regulation of human acetyl-CoA carboxylase[J]. Nature, 2018, 558(7710): 470-474.
[20] Svensson RU, Parker SJ, Eichner LJ, et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models[J]. Nat Med, 2016, 22(10): 1108-1119.
[21] Altea-Manzano P, Cuadros AM, Broadfield LA, et al. Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take[J]. EMBO Rep, 2020, 21(10): e50635.
[22] 颜新建, 李高峰, 唐梅, 等. 下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响[J].中国应用生理学杂志, 2019, 35(6): 543-547.
[23] Greenlee JD, Subramanian T, Liu K, et al. Rafting down the metastatic cascade: The role of lipid rafts in cancer metastasis, cell death, and clinical outcomes[J]. Cancer Res, 2021, 81(1): 5-17.
[24] 宋海岩, 张毅敏, 连辉, 等. 低氧条件下奥巴克拉联合吉西他滨对乳腺癌细胞的作用[J]. 中国应用生理学杂志, 2020, 36(3): 268-272.
[25] Saxena K, Jolly MK, Balamurugan K. Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis[J]. Transl Oncol, 2020, 13(11): 100845.